Tower Research Capital LLC (Trc) Annovis Bio, Inc. Transaction History

Tower Research Capital LLC (Trc)

$4.87 Billion
Q4 2024

A detailed history of Tower Research Capital LLC (Trc) transactions in Annovis Bio, Inc. stock. As of the latest transaction made, Tower Research Capital LLC (Trc) holds 1,768 shares of ANVS stock, worth $2,616. This represents 0.0% of its overall portfolio holdings.

Number of Shares

1,768

Previous 3,087 42.73%

Holding current value

$2,616

Previous $24,000 66.67%

% of portfolio

0.0%

Previous 0.0%

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 13, 2025	SELL	$4.37 - $9.87 $5,764 - $13,018	-1,319 Reduced 42.73%	1,768 $8,000
Q3 2024 Nov 14, 2024	SELL	$5.27 - $15.46 $19,873 - $58,299	-3,771 Reduced 54.99%	3,087 $24,000
Q2 2024 Aug 13, 2024	BUY	$4.82 - $18.01 $9,929 - $37,100	2,060 Added 42.93%	6,858 $39,000
Q1 2024 May 15, 2024	BUY	$8.47 - $18.93 $37,064 - $82,837	4,376 Added 1036.97%	4,798 $57,000
Q4 2023 Feb 13, 2024	SELL	$5.55 - $19.62 $1,221 - $4,316	-220 Reduced 34.27%	422 $7,000
Q3 2023 Nov 14, 2023	BUY	$9.37 - $14.12 $1,152 - $1,736	123 Added 23.7%	642 $6,000
Q2 2023 Aug 14, 2023	SELL	$11.95 - $16.31 $24,401 - $33,305	-2,042 Reduced 79.73%	519 $7,000
Q1 2023 May 09, 2023	BUY	$12.33 - $22.1 $12,773 - $22,895	1,036 Added 67.93%	2,561 $39,000
Q4 2022 Feb 10, 2023	SELL	$10.99 - $13.8 $1,813 - $2,277	-165 Reduced 9.76%	1,525 $21,000
Q3 2022 Nov 10, 2022	BUY	$10.26 - $21.81 $17,339 - $36,858	1,690 New	1,690 $23,000
Q1 2022 May 12, 2022	SELL	$11.84 - $19.78 $7,920 - $13,232	-669 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$17.58 - $37.67 $7,770 - $16,650	442 Added 194.71%	669 $12,000
Q3 2021 Nov 15, 2021	BUY	$30.95 - $120.97 $7,025 - $27,460	227 New	227 $7,000
Q2 2021 Aug 16, 2021	SELL	$21.55 - $96.1 $48,681 - $217,089	-2,259 Closed	0 $0
Q1 2021 May 17, 2021	BUY	$8.15 - $38.44 $12,070 - $56,929	1,481 Added 190.36%	2,259 $63,000
Q4 2020 Feb 16, 2021	SELL	$4.36 - $7.54 $1,996 - $3,453	-458 Reduced 37.06%	778 $6,000
Q3 2020 Nov 16, 2020	BUY	$3.84 - $6.78 $798 - $1,410	208 Added 20.23%	1,236 $6,000
Q2 2020 Aug 13, 2020	BUY	$2.5 - $5.64 $2,570 - $5,797	1,028 New	1,028 $4,000

Others Institutions Holding ANVS

# of Institutions

Shares Held

1.99M

Call Options Held

348K

Put Options Held

535K

View Full List

About Annovis Bio, Inc.

Ticker ANVS
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 8,163,920
Market Cap $12.1M
Description
Annovis Bio, Inc., a clinical stage drug platform company, develops drugs to treat neurodegeneration. The company's lead compound is Buntanetap, an orally administered drug, which has completed Phase 2a clinical trials for the treatment of Alzheimer's disease (AD) and Parkinson's disease, as well as is in clinical trials for Alzheimer's disease ...

More about ANVS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Tower Research Capital LLC (Trc), based on Form 13F filings with the SEC.

News

Stay updated on Tower Research Capital LLC (Trc) with notifications on news.

Account

Tower Research Capital LLC (Trc) Annovis Bio, Inc. Transaction History